Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Journal article
Keng MJ. et al, (2021), Value in Health
A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions.
Journal article
Chan MS. et al, (2021), J Gerontol A Biol Sci Med Sci
The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs.
Journal article
Herrett E. et al, (2021), Health Technol Assess, 25, 1 - 62
Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials.
Journal article
Herrett E. et al, (2021), BMJ, 372
Statin treatment and muscle symptoms: a series of randomised, placebo controlled N-of-1 trials
Journal article
ARMITAGE J., (2020), BMJ: British Medical Journal
Comparison of four methods to measure haemoglobin concentrations in whole blood donors ( COMPARE ): A diagnostic accuracy study
Journal article
Bell S. et al, (2020), Transfusion Medicine
Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
Conference paper
Rocca B. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2926 - 2926
Use of run-in periods in randomized trials
Journal article
Huo X. and ARMITAGE J., (2020), JAMA: Journal of the American Medical Association
Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants
Conference paper
Hammami I. et al, (2019), EUROPEAN HEART JOURNAL, 40, 265 - 265
Serious Adverse Effects of Extended-Release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial.
Journal article
Haynes R. et al, (2019), Clin Ther
Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA): A multicenter, randomized, placebo controlled trial.
Journal article
Kitas GD. et al, (2019), Arthritis Rheumatol
Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials.
Journal article
Offer A. et al, (2019), JAMA Netw Open, 2
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
Journal article
ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1529 - 1539
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.
Journal article
ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1540 - 1550
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.
Journal article
Clarke RJ. et al, (2018), JAMA Cardiol, 3, 781 - 782
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.
Journal article
Beveridge LA. et al, (2018), J Am Heart Assoc, 7
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
Journal article
Berlanga-Taylor AJ. et al, (2018), EBioMedicine, 31, 133 - 142
Ezetimibe: Likely to Be Beneficial For All.
Journal article
Herrington WG. et al, (2018), Circulation, 137, 1583 - 1584
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes.
Journal article
Bowman L. et al, (2018), Am Heart J, 198, 135 - 144
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Journal article
Aung T. et al, (2018), JAMA Cardiol, 3, 225 - 234